Q4 2017 Holdings
Filed 2018-02-14 | 98 holdings | $218.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $55.1M | 2,233,416 | 25.2% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $35.4M | 7,213,393 | 16.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $31.6M | 789,000 | 14.4% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $24.2M | 741,016 | 11.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $23.1M | 365,961 | 10.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $16.3M | 2,469,580 | 7.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $15.9M | 753,322 | 7.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $15.0M | 262,984 | 6.9% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $130.1K | 5,766,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $105.9K | 2,503,611 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $92.6K | 6,341,894 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $88.0K | 1,534,211 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $85.7K | 3,343,045 | 0.0% |
| Avexis Inc | COM | 05366U100 | $83.6K | 755,798 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $81.8K | 812,484 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $68.9K | $74,100,000 | 0.0% |
| Lannet Inc | COM | 516012101 | $63.0K | 2,717,287 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $61.6K | 394,801 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $52.5K | 1,709,400 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $51.8K | 2,105,180 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $51.7K | 1,522,566 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $48.7K | 705,573 | 0.0% |
| Isis Pharmaceuticals Inc del | NOTE 1.000%11/1 | 464337AJ3 | $48.4K | $45,700,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $47.6K | 1,468,341 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $45.8K | $75,000,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $44.8K | 339,180 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $43.6K | 568,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $42.1K | 1,000,680 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $39.5K | $48,000,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $37.2K | 1,190,516 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $36.1K | $40,500,000 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $35.8K | 1,000,000 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $32.8K | 1,858,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $32.4K | 3,955,494 | 0.0% |
| Davita Inc(DVA) | COM | 23918K108 | $30.7K | 425,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $29.9K | 396,000 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $29.3K | 130,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $28.9K | 484,055 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $28.9K | $27,600,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $28.9K | $36,000,000 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $26.3K | 2,920,856 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $26.1K | 615,000 | 0.0% |
| Envision Healthcare Corp | COM | 29414D100 | $23.4K | 676,000 | 0.0% |
| K2m Group Hldgs Inc | NOTE 4.125% 8/1 | 48273JAB3 | $22.8K | $20,000,000 | 0.0% |
| Depomed Inc | NOTE 2.500% 9/0 | 249908AA2 | $22.8K | $27,019,000 | 0.0% |
| Amag Pharmaceuticals Inc | NOTE 3.250% 6/0 | 00163UAD8 | $21.8K | $25,250,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $21.0K | 1,300,448 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $17.7K | 1,264,000 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $17.6K | 1,013,916 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $17.6K | 1,901,685 | 0.0% |